Cargando…

Relationship between Obesity, Adipocytokines and Inflammatory Markers in Type 2 Diabetes: Relevance for Cardiovascular Risk Prevention

This study aimed to analyse the impact of obesity in type 2 diabetes (T2D) on adipocytokines (adiponectin, leptin and resistin) and inflammatory markers (TNF-α, IL-6 and hsCRP) as cardiovascular risk factors. A cross-sectional study comparing the basal levels of adipocytokines and inflammatory marke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajkovic, Natasa, Zamaklar, Miroslava, Lalic, Katarina, Jotic, Aleksandra, Lukic, Ljiljana, Milicic, Tanja, Singh, Sandra, Stosic, Ljubica, Lalic, Nebojsa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024989/ https://www.ncbi.nlm.nih.gov/pubmed/24736687 http://dx.doi.org/10.3390/ijerph110404049

Ejemplares similares

Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
por: Lalić, Katarina, et al.
Publicado: (2015)

Hypertension in Obese Type 2 Diabetes Patients is Associated with Increases in Insulin Resistance and IL-6 Cytokine Levels: Potential Targets for an Efficient Preventive Intervention
por: Lukic, Ljiljana, et al.
Publicado: (2014)

Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes
por: Jotic, Aleksandra, et al.
Publicado: (2020)

Impact of acute hyperglycemia on layer-specific left ventricular strain in asymptomatic diabetic patients: an analysis based on two-dimensional speckle tracking echocardiography
por: Bogdanović, Jelena, et al.
Publicado: (2019)

The Inflammatory and Hemostatic Cardiovascular Risk Markers During Acute Hyperglycemic Crisis in Type 1 and Type 2 Diabetes
por: Popovic, Dragana, et al.
Publicado: (2019)

High Risk First Degree Relatives of Type 1 Diabetics: An Association with Increases in CXCR3(+) T Memory Cells Reflecting an Enhanced Activity of Th1 Autoimmune Response
por: Milicic, Tanja, et al.
Publicado: (2014)

Targeting Mitochondria in Diabetes
por: Krako Jakovljevic, Nina, et al.
Publicado: (2021)

Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke
por: Jotic, Aleksandra, et al.
Publicado: (2015)

Type 2 Diabetic Patients with Ischemic Stroke: Decreased Insulin Sensitivity and Decreases in Antioxidant Enzyme Activity Are Related to Different Stroke Subtypes
por: Jotic, Aleksandra, et al.
Publicado: (2013)

Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease
por: Seferovic, Jelena P., et al.
Publicado: (2018)

Prevalence and Metabolic Predictors for Early Diagnosed Prediabetes in Women with Previous Gestational Diabetes: Observational Cohort Study
por: Jotic, Aleksandra Z., et al.
Publicado: (2021)

Development of ALOHa-G Risk Score for Detecting Postpartum Dyslipidemia Among Normoglycemic Women with Previous Gestational Diabetes: Observational Cohort Study
por: Jotic, Aleksandra Z., et al.
Publicado: (2023)

Distribution of normal and pathological OGTTs among pregnant population and non-pregnant women with PCOS – the cross-sectional study
por: Gojnic-Dugalic, Miroslava, et al.
Publicado: (2021)

Maternal and Fetal Outcomes among Pregnant Women with Diabetes
por: Gojnic, Miroslava, et al.
Publicado: (2022)

Trends of the Prevalence of Pre-gestational Diabetes in 2030 and 2050 in Belgrade Cohort
por: Dugalic, Stefan, et al.
Publicado: (2022)

The Case for: Hypoglycemia Is of Cardiovascular Importance
por: Lalic, Nebojsa M.
Publicado: (2013)

mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
por: Kezic, Aleksandra, et al.
Publicado: (2018)

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2018)

Obesity, Adipocytokines and Cancer
por: Masaki, Takayuki, et al.
Publicado: (2008)

ADIPOCYTOKINES AND OBESITY-LINKED DISORDERS
por: OUCHI, NORIYUKI, et al.
Publicado: (2012)

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
por: Scrivo, Rossana, et al.
Publicado: (2013)

Obesity and breast cancer: inflammatory and adipocytokine correlations
por: Matafome, Paulo C, et al.
Publicado: (2010)

Invasive Diagnostic Procedures from Bronchoscopy to Surgical Biopsy—Optimization of Non-Small Cell Lung Cancer Samples for Molecular Testing
por: Lalić, Nensi, et al.
Publicado: (2023)

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2016)

Associations of Adipocytokines with The Development of Cardiovascular Events in Young People
por: Khudiakova, Alena D., et al.
Publicado: (2023)

Adipocytokines and autoimmunity
por: Frommer, Klaus W, et al.
Publicado: (2011)

Double‐blind, randomised, placebo‐controlled trial on the effect of L‐carnitine and L‐acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia
por: Micic, Sava, et al.
Publicado: (2019)

Adipocytokines – mediators of fat tissue linking obesity and cancer
por: Ratke, J, et al.
Publicado: (2009)

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2019)

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Report from the 5th cardiovascular outcome trial (CVOT) summit
por: Schnell, Oliver, et al.
Publicado: (2020)

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Development and Validation of an HPLC Method for Simultaneous Determination of Capsaicinoids and Camphor in Over-the-Counter Medication for Topical Use
por: Lalić, Martin, et al.
Publicado: (2022)

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy
por: Matsuda, M
Publicado: (2020)

The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease
por: Cai, Meichao, et al.
Publicado: (2023)

Coping with the burden of the COVID-19 pandemic: a cross-sectional study of community pharmacists from Serbia
por: Jovičić-Bata, Jelena, et al.
Publicado: (2021)

Adipocytokines in obese Ghanaian subjects with or without type 2 diabetes
por: Adams, Yussif, et al.
Publicado: (2018)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Adipocytokines: The pied pipers
por: Gandhi, Hardik, et al.
Publicado: (2010)

Adipocytokines in Thyroid Dysfunction
por: Aydogan, Berna İmge, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uhekanbc05julvjq4vdsph0v3j